MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Turning Facility Data Into ROI: Where Healthcare Leaders Should Start
Better data, smarter tools and small facility upgrades can drive measurable returns, guide ambulatory strategy and improve patient experience.
Sutter Health Breaks Ground on Advanced Cancer Center and Care Complex
The new center, located on Sutter’s Memorial Medical Center campus, will feature four stories and 165,000 square feet of modernized, patient-centered space.
Imperial Beach Community Clinic Caught Up in Email Cyberattack
The unusual activity they detected occurred between February 4, 2025, to May 2, 2025.
Social Media Driving Rise in Trade Jobs
Social media is the second largest career influencer for Gen Zers.
North Carolina Children's Receives $25M Gift from Coca-Cola Consolidated
The gift is the first step towards the goal of raising more than $1 billion for the new NC Children’s campus in Apex.